Description: Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for the treatment of cardiovascular diseases; the gastrointestinal tract; central nervous system; pain relief; anti-infectives; blood and blood-forming organs; urological; diabetes; and oncology. The company also provides non-prescription products, such as products for oral cavity and pharynx; cough and cold products; analgesics; nasal products; vitamin and mineral products; products for enhancing cerebral and peripheral circulation; products for enhancing digestive tract and digestion; health care products; and others. In addition, it offers animal health products comprising antiinfectives, antiparasitics, and other products for farm and companion animals. Further, the company provides health resort and tourist services. Krka, d. d. was founded in 1954 and is headquartered in Novo Mesto, Slovenia.
Home Page: www.krka.biz
Šmarješka cesta 6
Novo Mesto,
8501
Slovenia
Phone:
386 7 331 2111
Officers
| Name | Title |
|---|---|
| Dr. Jo?e Colaric | Pres of Management Board & CEO |
| Dr. Ales Rotar Ph.D. | Member of the Management Board and Director of Pharmaceutical R&D & Production |
| Mr. David Bratoz | Member of the Management Board |
| Dr. Vinko Zupancic Ph.D. | Director of API R&D, Production & Supply Chain and Member of the Management Board |
| Ms. Milena Kastelic | Member of the Mgt. Board, Worker Director & Deputy Dir. of Pharmaceutical Production |
| Magistrate Toma? Sever | Deputy Director of Sales & Independent Employee Representative Member of Supervisory Board |
| Dr. Mateja Vrecer | Director of Quality Management & Independent Employee Representative Member of Supervisory Board |
| Mr. Brane Kastelec M.S., MSc | Director of Fin. |
| Mr. Borut Lek?e | Deputy CEO of Legal Affairs & Head of Legal Affairs |
| Ms. Elvira Medved | Head of PR |
Exchange: WAR
Country: PL
Currency: Polish złoty (zł)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 8.3214 |
| Price-to-Book MRQ: | 1.3864 |
| Price-to-Sales TTM: | 8.5173 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 11489 |